To avert the menace of pathogens in medical parlance, emerging attractive strategy is combining two different active fragments in a single molecule for scientific solutions. Trisubstituted imidazo[1,2-a]pyridine-carboxylate was engrossed as a hybrid with oxadiazole. The three dimensional and crystal structures of compounds 3-[5-(2-chlorophenyl)-1,3,4-oxadiazol-(4 e) were determined using single crystal X-ray diffraction studies and their crystal packing was analyzed using Hirshfeld surface computational analysis. The molecular conformation of 4 c (planar) and 4 e (twisted) and crystal packing is different and this may be due to substitution effect. In addition, both compounds have common intermolecular interactions of the type C-H…π and intercontacts H…H contributes more to the Hishfeld surfaces. Screening for microbial activity acknowledged, 2,8-dimethyl-3-[5-(3-nitrophenyl)-1,3,4-oxadiazol-2-yl] imidazo[1,2-a]pyridine (4 f) and 6-chloro-2-methyl-3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]imidazo[1,2-a]pyridine (4 g) as most effective against Staphyllococus aureus, over all other derivatives. Meanwhile, 4 f also showed pronounced antifungal activity against Candida albicans. Further 4 f was endorsed by time kill assay as bactericidal in its action.[a] S.